Loading…
Unified public record assembled from the source systems listed below. Amounts describe distinct reported activity and are not added into a single influence total.
Political giving
$0
Political receipts
$0
Lobbying income
$25,795,000
Lobbying expense
—
Federal awards
—
Relationships
157
| $320,000 |
| — |
| lobbied by | Pharmaceutical Research And Manufacturers Of America (phrma) | $320,000 | — |
| lobbied by | Pharmaceutical Research And Manufacturers Of America (phrma) | $320,000 | — |
| lobbied by | Eli Lilly And Company | $320,000 | — |
| lobbied by | Tiber Creek Group (on Behalf Of Vertex Pharmaceuticals) | $320,000 | — |
| lobbied by | Tiber Creek Group (on Behalf Of Vertex Pharmaceuticals) | $320,000 | — |
| lobbied by | Eli Lilly And Company | $310,000 | — |
| lobbied by | Novartis | $290,000 | — |
| lobbied by | Tiber Creek Group (on Behalf Of Vertex Pharmaceuticals) | $280,000 | — |
| lobbied by | Inc.) Tiber Creek Group (on Behalf Of Emd Serono | $260,000 | — |
| lobbied by | Novartis | $260,000 | — |
| lobbied by | Fresenius Medical Care North America | $240,000 | — |
| lobbied by | Genentech Inc | $240,000 | — |
| lobbied by | Pharmaceutical Research And Manufacturers Of America (phrma) | $240,000 | — |
| lobbied by | Novartis | $240,000 | — |
| lobbied by | Fresenius Medical Care North America | $240,000 | — |
| lobbied by | Tiber Creek Group (obo Jazz Pharmaceuticals) | $240,000 | — |
| lobbied by | Novartis | $240,000 | — |
| lobbied by | Inc. Comprehensive Health Management | $240,000 | — |
| lobbied by | Novartis | $240,000 | — |
| lobbied by | Genentech Inc | $240,000 | — |
| lobbied by | Novartis | $240,000 | — |
| lobbied by | Pharmaceutical Research And Manufacturers Of America (phrma) | $240,000 | — |
| lobbied by | Fresenius Medical Care North America | $240,000 | — |
| lobbied by | Fresenius Medical Care North America | $240,000 | — |
| lobbied by | Pharmaceutical Research And Manufacturers Of America (phrma) | $240,000 | — |
| lobbied by | Genentech Inc | $240,000 | — |
| lobbied by | Pharmaceutical Research And Manufacturers Of America (phrma) | $240,000 | — |
| lobbied by | Eli Lilly And Company | $240,000 | — |
| lobbied by | Pharmaceutical Research And Manufacturers Of America (phrma) | $240,000 | — |
| lobbied by | Genentech Inc | $240,000 | — |
| lobbied by | Novartis | $240,000 | — |
| lobbied by | Pharmaceutical Research And Manufacturers Of America (phrma) | $240,000 | — |
| lobbied by | Novartis | $240,000 | — |
| lobbied by | Novartis | $240,000 | — |
| lobbied by | Pharmaceutical Research And Manufacturers Of America (phrma) | $240,000 | — |
| lobbied by | Fresenius Medical Care North America | $240,000 | — |
| lobbied by | Novartis | $240,000 | — |
| lobbied by | Tiber Creek Group (obo Jazz Pharmaceuticals) | $240,000 | — |
| lobbied by | Daiichi Sankyo Inc | $230,000 | — |
| lobbied by | Novartis | $230,000 | — |
| lobbied by | Pharmaceutical Research And Manufacturers Of America (phrma) | $220,000 | — |
| lobbied by | Inc. Amgen | $210,000 | — |
| lobbied by | Inc. Amgen | $210,000 | — |
| lobbied by | Inc. Amgen | $210,000 | — |
| lobbied by | Inc.) Tiber Creek Group (on Behalf Of Emd Serono | $200,000 | — |
| lobbied by | Genentech Inc | $200,000 | — |